DealsKKR to acquire Biosynth Carbosynth from AmiraKKR is funding its investment through the firm’s Health Care Strategic Growth strategy.BySarah Pringle1 November 2021•4 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs